ATRA

all-trans retinoic acid

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for ATRA, covering 2015-07-07 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. [Phase 1]

See pricing